The company had posted a net loss of Rs 23.54 crore for the corresponding period of the previous fiscal, Panacea Biotec said in a filing to BSE.
Standalone total income from operations of the company stood at Rs 124.84 crore for the quarter under consideration as against Rs 150.55 crore in the same period a year ago.
Shares of Panacea Biotec today closed at Rs 156.80 per scrip on BSE, down 0.13 per cent from its previous close.